Drawing for GALIOS

USPTO serial 76207617

GALIOS

Reviewed by CopyMark Law Group

Reg. 2770689Status 710
Filing date
Status date
Registration date
Oct 7, 2003
Examiner
ESTRADA, LINDA M
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with GALIOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB150 E 42ND STNEW YORK, NY 10017-5612UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001CHEMICALS USED IN INDUSTRY AND SCIENCE, NAMELY, OLIGONUCLEOTIDES, AQUEOUS SOLUTIONS, DYES, ORGANIC SOLVENTS ALL FOR SCIENTIFIC OR MEDICAL RESEARCH USE, KITS COMPRISED OF OLIGONUCLEOTIDES, AQUEOUS SOLUTIONS, DYES, ORGANIC SOLVENTS FOR SCIENTIFIC RESEARCH USE IN NUCLEIC ACID ANALYTICSSECTION 8 - CANCELLED—
005CHEMICALS PRODUCTS FOR DIAGNOSTIC PURPOSES, NAMELY, OLIGONUCLEOTIDES, AQUEOUS SOLUTIONS, DYES, ORGANIC SOLVENTS ALL FOR CLINICAL OR MEDICAL LABORATORY USES; KITS COMPRISED OF OLIGONUCLEOTIDES, AQUEOUS SOLUTIONS, DYES, ORGANIC SOLVENTS FOR CLINICAL OR MEDICAL LABORATORY USE MEDICAL LABORATORY USES TO DETERMINE NUCLEIC ACID LEVELSECTION 8 - CANCELLED—
042ANALYTIC-DIAGNOSTIC LABORATORY SERVICES, NAMELY, LABORATORY RESEARCH SERVICES IN THE FIELDS OF MOLECULAR BIOLOGY, PHARMACOGENETICS, GENETIC ANALYSIS, THERANOSTICS, DRUG DEVELOPMENTSSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 15, 2010C8..CANCELLED SEC. 8 (6-YR)—
Mar 11, 2008CFITCASE FILE IN TICRS—
Sep 23, 2006CORVREVIEW OF CORRESPONDENCE COMPLETE—
Aug 21, 2006MAILPAPER RECEIVED—
Oct 7, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 15, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 25, 2003NPUBNOTICE OF PUBLICATION—
May 16, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 16, 20031.BDSec. 1(B) CLAIM DELETED—
Feb 6, 200344DDSEC. 44(D) CLAIM DELETED—
Mar 20, 2002CNSLLETTER OF SUSPENSION MAILED—
Feb 6, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 4, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 15, 2001CNSLLETTER OF SUSPENSION MAILED—
Nov 14, 2001DOCKASSIGNED TO EXAMINER—
Sep 21, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 17, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 6, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance